DIDO 3 [SpacePharma]
The DIDO satellites are 3U CubeSat satellites for micro-gravity rersearch designed by the Israeli / Swiss company SpacePharma.
The satellites contain the mGnify miniaturized end-to-end lab, that can be remote controlled from anywhere. The mGnify unit can perform experiments on bacterial growth, antibiotics resistance, self-assembly, enzymatic reactions, polymerization, nanoparticle synthesis, particle aggregation dynamics, emulsion stability and crystallization.
Upgrades have been made to the DIDO-3 platform to be able to support dedicating more power to the payload, allowing it to maintain higher temperatures than the previous mission, DIDO-2.
A third mission, DIDO 3, was ordered in 2018. It is to fly in 2019 on a multi satellite launch on a Vega rocket.
|Type / Application:||Micro-gravity research|
|Power:||Solar cells, batteries|
|Orbit:||496 km × 508 km, 97.51° (#2)|
|DIDO 3||-||2020||Ko ELV||Vega||with Athena, ION CubeSat Carrier, ESAIL, UPMSat 2, NEMO-HD, ŃuSat 6, GHGSat C1, Flock-4v 1, ..., 26, Lemur-2 112, ..., 119, SpaceBEE 10, ..., 21, FSSCat A, B, NAPA 1, TARS, Tyvak 0171, OSM 1 CICERO, PICASSO, SIMBA, TRISAT, AMICal-Sat, TTÜ100|